Biovie Inc. SEC filings BIVIW
Biovie Inc. has 507 filings in SEC EDGAR's recent list, going back to Jul 2, 2013. Its latest annual report, Form 10-K, was filed on Aug 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 11, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| 424B5 | Prospectus supplement | Sep 14, 2026 | — |
| S-1/A | Amended registration statement | Aug 14, 2026 | — |
| FWP | Free writing prospectus | Aug 7, 2026 | — |
| FWP | Free writing prospectus | Aug 6, 2026 | — |
| FWP | Free writing prospectus | Aug 6, 2026 | — |
| S-1/A | Amended registration statement | Aug 6, 2026 | — |
| S-1/A | Amended registration statement | Jul 31, 2026 | — |
| S-1 | Registration statement | Jul 17, 2026 | — |
| S-3 | Shelf registration | Jun 18, 2026 | — |
| S-8 | Employee stock plan registration | Nov 25, 2025 | — |
| POS AM | Filing | Oct 6, 2025 | — |
| 424B3 | Prospectus | Oct 6, 2025 | — |
| 424B5 | Prospectus supplement | Aug 8, 2025 | — |
| S-1/A | Amended registration statement | Aug 4, 2025 | — |
| S-1/A | Amended registration statement | Jul 22, 2025 | — |
| S-1/A | Amended registration statement | Jul 11, 2025 | — |
| S-1 | Registration statement | Jul 3, 2025 | — |
| 424B3 | Prospectus | Dec 2, 2024 | — |
| S-1/A | Amended registration statement | Nov 27, 2024 | — |
| S-8 | Employee stock plan registration | Nov 22, 2024 | — |
| S-1 | Registration statement | Nov 21, 2024 | — |
| 424B5 | Prospectus supplement | Oct 29, 2024 | — |
| 424B5 | Prospectus supplement | Oct 24, 2024 | — |
| 424B5 | Prospectus supplement | Oct 22, 2024 | — |
| 424B5 | Prospectus supplement | Sep 25, 2024 | — |
| 424B5 | Prospectus supplement | Sep 24, 2024 | — |
| 424B5 | Prospectus supplement | Sep 23, 2024 | — |
| 424B5 | Prospectus supplement | Mar 4, 2024 | — |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| 424B3 | Prospectus | Aug 29, 2023 | — |
| S-3 | Shelf registration | Aug 18, 2023 | — |
| 424B3 | Prospectus | Apr 14, 2023 | — |
| 424B5 | Prospectus supplement | Apr 7, 2023 | — |
| S-3 | Shelf registration | Mar 31, 2023 | — |
| 424B5 | Prospectus supplement | Dec 23, 2022 | — |
| 424B5 | Prospectus supplement | Dec 15, 2022 | — |
| 424B5 | Prospectus supplement | Dec 6, 2022 | — |
| S-1 | Registration statement | Nov 10, 2022 | — |
| 424B5 | Prospectus supplement | Sep 30, 2022 | — |
| 424B5 | Prospectus supplement | Aug 31, 2022 | — |
| S-8 | Employee stock plan registration | Oct 4, 2021 | — |
| 424B5 | Prospectus supplement | Aug 10, 2021 | — |
| FWP | Free writing prospectus | Aug 6, 2021 | — |
| 424B5 | Prospectus supplement | Aug 6, 2021 | — |
| S-3 | Shelf registration | Jan 22, 2021 | — |
| 424B4 | Prospectus | Sep 18, 2020 | — |
| S-1MEF | Filing | Sep 17, 2020 | — |
| S-1/A | Amended registration statement | Sep 8, 2020 | — |
| S-1/A | Amended registration statement | Aug 21, 2020 | — |
| S-1/A | Amended registration statement | Jul 15, 2020 | — |
| S-1/A | Amended registration statement | Mar 11, 2020 | — |
| S-1/A | Amended registration statement | Nov 22, 2019 | — |
| S-1/A | Amended registration statement | Nov 1, 2019 | — |
| S-1/A | Amended registration statement | Oct 9, 2019 | — |
| S-1/A | Amended registration statement | Oct 4, 2019 | — |
| S-1/A | Amended registration statement | Oct 2, 2019 | — |
| S-1/A | Amended registration statement | Aug 8, 2019 | — |
| S-1/A | Amended registration statement | Jul 9, 2019 | — |
| S-1/A | Amended registration statement | Jul 1, 2019 | — |
| S-1/A | Amended registration statement | Jun 28, 2019 | — |
| S-1 | Registration statement | Apr 30, 2019 | — |
| POS AM | Pos am no.1 | Apr 18, 2019 | — |
| 424B3 | Prospectus | Apr 3, 2017 | — |
| 424B3 | Prospectus | Apr 3, 2017 | — |
| S-1/A | Amended registration statement | Mar 29, 2017 | — |
| S-1/A | Amended registration statement | Mar 10, 2017 | — |
| S-1 | Registration statement | Jan 19, 2017 | — |
| S-1/A | Amended registration statement | Nov 5, 2013 | — |
| S-1/A | Amended registration statement | Oct 15, 2013 | — |
| S-1/A | Amended registration statement | Sep 26, 2013 | — |
| S-1 | Registration statement | Aug 15, 2013 | — |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BIVI (Nasdaq), BIVIW (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Carson City, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1580149
- Former names
- NANOANTIBIOTICS, INC. (until Jul 22, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.